Skip to main content

Table 2 Allele odds ratios analysis between probable SARS patients and other groups

From: Association of HLA class I with severe acute respiratory syndrome coronavirus infection

 

33 Cases

Probable

SARS

patients

28 fever

patients

Control A

101 high risk non-infected

health care workers

Control B†

190 healthy unrelated Taiwanese

HLA alleles

Total number of alleles

n = 66

Total number of alleles

n = 56

P

Total number of alleles

n = 202

OR†

CI

P

Total number of alleles

n = 380

OR‡

CI

P

B* 4601/B46

15

9

n.s.

25

2.08

1.04–4.24

0.04

52

1.86

1.02–3.54

0.06

B* 1301/B13

1

3

n.s.

18

0.16

0.02–1.00

0.03

34

0.16

0.02–0.97

0.02

B* 5401/B54

5

3

n.s.

3

5.44

1.26–23.41

0.02

15

1.99

1.01–5.69

n.s.

B* 3901/B39

5

2

n.s.

6

2.68

0.78–9.08

n.s.

8

3.81

1.21–12.03

0.03

  1. P = P-value n.s. = not significant. † In control B, HLA-A and B were defined by serological methods. Consequently data were re-analyzed after converting allotypes of probable SARS patients to their serological equivalents [8]. ‡Odds ratio (OR) refers to Woolf-Haldane odds ratios, with 95% Woolf approximation confidence intervals (CI) and corresponding two tails Fisher P-values. Note: No corrected P-values (Pc-values) were significant; consequently Pc-values were not indicated.